ConvaTec stock gains as revenue rises to GBP 2.439 billion

Published on 09/23/2026 at 11:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

ConvaTec stock traded at 215.20 GBX on September 23, 2026, up 0.19 percent. Fiscal 2025 revenue reached GBP 2.439 billion versus GBP 2.289 billion.

Moderne Medizintechnik-Reinraumfertigung mit Technikern an steriler Produktionslinie — ConvaTec Group Plc GB00BD3VFW73 zeigt moderne Medizintechnik-Fertigung mit sterilen Produktionslinien und Reinraumtechnikern, Illustration mit AI erstellt.

ConvaTec Group plc (GB00BD3VFW73) traded at 215.20 GBX on the London Stock Exchange at 11:35:59 on September 23, 2026, up 0.19 percent, with volume of 4.18 million shares. The latest market move follows fiscal 2025 revenue of GBP 2.439 billion, compared with GBP 2.289 billion in fiscal 2024, according to Ad-hoc-News on September 22, 2026.

Revenue expands by GBP 150 million

The fiscal 2025 revenue figure was GBP 150 million higher than the GBP 2.289 billion recorded in fiscal 2024, an increase of about 6.6 percent. The same fiscal-year comparison showed gross profit of GBP 1.384 billion versus GBP 1.299 billion and net income of GBP 175 million versus GBP 190.5 million, according to Ad-hoc-News on September 22, 2026.

The comparison is mixed: revenue and gross profit increased, while net income declined by GBP 15.5 million, or about 8.1 percent. That split gives the stock a more specific earnings signal than revenue growth alone, because investors must weigh top-line expansion against the lower reported bottom line.

London quote holds above 214 GBX

The latest London quotation stood at 215.20 GBX, while the same market snapshot showed an intraday high of 217.20 GBX and a low of 213.80 GBX on September 23, 2026. The stock therefore traded 1.40 GBX below the session high and 1.40 GBX above the session low, with the quoted daily gain amounting to 0.40 GBX.

A previous London snapshot placed the shares at 214.80 GBX on September 22, 2026, up 0.37 percent, with a day high of 216.00 GBX, a low of 212.80 GBX and volume of 3.56 million shares. The latest 215.20 GBX quote is 0.40 GBX above that earlier close reference, while the September 23 market data show a larger volume of 4.18 million shares.

Analyst consensus uses a different currency

Ad-hoc-News reported on September 22, 2026 that MarketScreener listed 19 analysts with an average target price of USD 4.052 and a mean consensus of Buy. That target is presented in US dollars on the portal, while the primary London quotation remains in GBX, so the two figures are not directly interchangeable without a currency conversion.

The current evidence therefore combines a 215.20 GBX London price with fiscal 2025 revenue of GBP 2.439 billion, gross profit of GBP 1.384 billion and net income of GBP 175 million. Revenue growth is the positive comparison; the lower net income is the principal counterweight in the reported figures.

Stock trades at 215.20 GBX

ConvaTec stock traded at 215.20 GBX on the London Stock Exchange at 11:35:59 on September 23, 2026, with a daily gain of 0.19 percent and volume of 4.18 million shares. The dated market level and the fiscal 2025 revenue comparison provide the clearest measurable reference points for the shares.